跳至主要内容
临床试验/CTIS2022-502586-21-00
CTIS2022-502586-21-00招募中1 期

Clinical and endocrinological effects of letrozole during the luteal phase after controlled ovarian stimulation in oocyte donors: a low interventional, randomized, controlled trial - 2206-MAD-089-SC

Ivi Madrid S.L.0 个研究点目标入组 152 人开始时间: 2022年12月7日最近更新:

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
152

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • Women who have been accepted into IVI's oocyte donation programme. - Age between 18 and 34 years, inclusive. - Hyperresponsiveness to stimulation, defined as the presence of =18 follicles of size =11 mm on the day of the last ultrasound control visit prior to ovarian puncture. - Dated and signed informed consent.

排除标准

  • - Known allergy to letrozole. - Known lactose intolerance. - Participation in another clinical study, prior to inclusion in the present study, which could affect the objectives of the study in the opinion of the investigator.

研究者

发起方
Ivi Madrid S.L.

相似试验